Titan Pharmaceuticals
TTNP
$6.88
Share price
-2.55%
Change (1 day)
805.26%
Change (1 year)
Categories
EPS for Titan Pharmaceuticals (TTNP)
EPS in 2023 (TTM): -$0.57
According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -$0.57. In 2022 the company made an earnings per share (EPS) of -$0.77 an increase over its 2021 EPS that were of -$0.90.
EPS history for Titan Pharmaceuticals from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.57 | -25.97% |
| 2022 | -$0.77 | -14.44% |
| 2021 | -$0.90 | -83.46% |
| 2020 | -$5.44 | -81.27% |
| 2019 | -$29.06 | -49% |
| 2018 | -$56.98 | -53.11% |
| 2017 | -$121.53 | -361.29% |
| 2016 | $46.51 | -146.98% |
| 2015 | -$99.00 | 279.31% |
| 2014 | -$26.10 | -120.57% |
| 2013 | $126.90 | -153.41% |
| 2012 | -$237.60 | -7.69% |
| 2011 | -$257.40 | 160% |
| 2010 | -$99.00 | 0% |
| 2009 | -$99.00 | |
| 2007 | -$405.90 | -2.38% |
| 2006 | -$415.80 | -39.13% |
| 2005 | -$683.11 | -16.87% |
| 2004 | -$821.71 | -22.43% |
| 2003 | -$1,059 | 5.94% |
| 2002 | -$999.91 | 60.32% |
| 2001 | -$623.71 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $14.09 | -2,571.11% | 🇺🇸 USA |
 Novartis NVS | $3.74 | -756.14% | 🇨🇭 Switzerland |
 Vanda Pharmaceuticals VNDA | $0.27 | -147.37% | 🇺🇸 USA |
 Repligen
RGEN | $2.09 | -466.67% | 🇺🇸 USA |
 MediciNova MNOV | -$0.25 | -56.14% | 🇺🇸 USA |
 Celldex Therapeutics CLDX | -$2.40 | 321.05% | 🇺🇸 USA |